Elisa Agostinetto
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Elisa Agostinetto
Mar 29, 2024, 06:30 |
Insight
Elisa Agostinetto: Important meta-analysis in NPJ Journals Breast shedding light on one of the biggest unmet needs in breast oncology
Elisa Agostinetto, Medical Oncologist and Research Fellow at Jules Bordet Institute in Brussels, posted on…
Mar 22, 2024, 22:58 |
Blog
Elisa Agostinetto: Our subanalysis of the CLEOPATRA study led by Veronique Debien
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Mar 15, 2024, 15:38 |
Blog
Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Mar 12, 2024, 20:36 |
Societies
Elisa Agostinetto: Happy to receive a ESMO Merit Travel Grant for the upcoming ESMO Breast24
Elisa Agostinetto, Research Fellow at Jules Bordet Institute in Brussels, shared a post on X/Twitter: "Happy to receive…
Feb 16, 2024, 18:13 |
Blog
Elisa Agostinetto: Nice editorial out in Journal of Clinical Oncology on the design, analysis, and reporting of research that involves real-world data
Elisa Agostinetto, Research Fellow at Jules Bordet Institute, shared a post on X/Twitter: "Nice editorial out…
Jan 28, 2024, 18:29 |
Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
Dec 20, 2023, 12:00 |
Insight
Elisa Agostinetto: Blinded independent central review (BICR) in clinical trials is it really needed
Elisa Agostinetto, Medical Research Fellow at Jules Bordet Institute in Brussels, recently posted X/Twitter: ''Blinded…
Dec 17, 2023, 17:26 |
Blog
25 Posts Not To Miss From SABCS 2023
The San Antonio Breast Cancer Symposium 2023 (SABCS 2023) took place in San Antonio, Texas…
Nov 16, 2023, 17:35 |
Blog
Daniel Portik: Full house at the Young Cancer Professionals meeting of the European Cancer Summit hosted by European Cancer Organisation
Daniel Portik, RTQA Fellow at EORTC, shared a post on LinkedIn: “Full house at the…
Oct 4, 2023, 21:11 |
Blog
Elisa Agostinetto: Proud to be part of Institut Jules Bordet team and to work everyday with extraordinary colleagues and mentors to help fight against breast cancer.
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared the following post on Twitter: "This…
1
2
3
All:
30
Posts:
21 - 30
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube